January 18, 2018 / 9:08 PM / Updated 8 minutes ago BRIEF-European Commission Approves Amgen, Allergan's Mvasi Reuters Staff 1 Min Read 
Jan 18 (Reuters) - Amgen Inc: 
* EUROPEAN COMMISSION APPROVES AMGEN AND ALLERGAN‘S MVASI® (BIOSIMILAR BEVACIZUMAB) FOR THE TREATMENT OF CERTAIN TYPES OF CANCER 
* AMGEN INC - EUROPEAN COMMISSION HAS GRANTED MARKETING AUTHORIZATION FOR MVASI Source text for Eikon: Further company coverage: